Catalio Access Fund VIII, LLC
Reporting owner on Forms 3, 4 and 5, CIK 2126358.
- In the filer group Catalio Capital Management, LP
Catalio Access Fund VIII, LLC reported on 1 issuer in 1 filing, the latest a Form 3 filed 2026-10-14.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Iambic Therapeutics, Inc. CIK 1997038 | 10% owner | 1 | 2026-10-14 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Iambic Therapeutics, Inc. Series A Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B-3 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Series B-4 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Iambic Therapeutics, Inc. Convertible Promissory Notes, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 3 0001958125-26-000010 | Iambic Therapeutics, Inc. | 2026-10-14 |